SNS-062 — clinical trials using this drug

Public-registry trials using SNS-062 that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.

Trial	Sponsor	Condition	Phase	Sites
Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers	Sunesis Pharmaceuticals	Chronic Lymphocytic Leukemia	PHASE1 / PHASE2	11

Registry history

First registered study	January 2017 — NCT03037645 (Sunesis Pharmaceuticals)
Registered studies matching this name	1 all-time · 0 currently recruiting

Source: ClinicalTrials.gov, the public trial registry.

Free site-risk snapshot for any of these trials

Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related drugs & trials

Other Chronic Lymphocytic Leukemia drugs

← Eichor home · All tracked trials · Chronic Lymphocytic Leukemia studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →